Early circulating tumour DNA (ctDNA) dynamics for predicting and monitoring response to immunotherapy(IO) vs chemotherapy (CT) in patients with 1L metastatic (m) NSCLC: Analyses from the phase 3 MYSTIC trial Meeting Abstract
| Authors: | Peters, S.; Rizvi, N.; Kuziora, M.; Lai, Z.; Shrestha, Y.; Dey, A.; Barrett, J. C.; Scheuring, U.; Poole, L.; Abbosh, C.; Raja, R.; Hellmann, M.; Panse, J. |
| Abstract Title: | Early circulating tumour DNA (ctDNA) dynamics for predicting and monitoring response to immunotherapy(IO) vs chemotherapy (CT) in patients with 1L metastatic (m) NSCLC: Analyses from the phase 3 MYSTIC trial |
| Meeting Title: | 2022 Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 45 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Nov 13-16 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2022-11-01 |
| Start Page: | 149 |
| Language: | English |
| ACCESSION: | WOS:000883051700351 |
| PROVIDER: | wos |
| DOI: | 10.1159/000521004 |
| Notes: | Meeting Abstract: 218 -- Source: Wos |
